Advisory Research Inc Rx Sight, Inc. Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$20.91 - $40.9 $181,477 - $354,971
-8,679 Reduced 5.56%
147,510 $5.95 Million
Q3 2023

Nov 13, 2023
BUY
$27.05 - $33.37 $1.55 Million - $1.91 Million
57,309 Added 57.96%
156,189 $4.36 Million
Q2 2023

Aug 14, 2023
BUY
$16.37 - $28.9 $1.62 Million - $2.86 Million
98,880 New
98,880 $2.85 Million

Others Institutions Holding RXST

# of Institutions
225
Shares Held
32.3M
Call Options Held
394K
Put Options Held
32K
View Full List

About RxSight, Inc.

RXST Quotes by TradingView
  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.27B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email